Properties
Description
Chetomin is designed to disrupt the hypoxia-inducible factor (HIF) pathway, aiming to hinder cancer cell survival and adaptation in low-oxygen environments characteristic of tumor growth. It targets HIF-1.
Molecular Formula
C31H30N6O6S4
Identity
Confirmed by NMR/HPLC/MS.
Applications
Chetomin is used to inhibit hypoxia-inducible factors, thereby offering potential therapeutic benefits in targeting tumor growth and angiogenesis.
